These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2402940)

  • 1. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Kriazheva SS; Butov IuS
    Vestn Dermatol Venerol; 1990; (5):4-6. PubMed ID: 2402940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K
    Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etretinate (Tigason) for skin disease.
    Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967
    [No Abstract]   [Full Text] [Related]  

  • 11. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH
    S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous lupus erythematosus with etretinate.
    Ruzicka T; Meurer M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(4):324-9. PubMed ID: 2413687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of dyskeratosis follicularis (Darier's disease) with aromatic retinoid].
    Rubisz-Brzezińska J
    Przegl Dermatol; 1987; 74(6):443-8. PubMed ID: 3330247
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tigason in the treatment of psoriasis and various dermatoses].
    Kalamkarian AA; Marzeeva GI; Chistiakova IA; Kirsanova MM; Mel'kumov AV
    Vestn Dermatol Venerol; 1985 Jul; (7):4-7. PubMed ID: 4050091
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses.
    Viglioglia PA
    Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S; Lidén S
    Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Darier's disease and renal polycystosis. Familial study and effects of aromatic retinoid].
    Claudy A; Toulon J; Dutoit M; Sabatier JC; Berthoux FC
    Ann Dermatol Venereol; 1981; 108(8-9):675-7. PubMed ID: 7316395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of congenital erythroderma ichthyosiforme in mother and son with the oral aromatic retinoid Ro 10-9359. The need for maintenance therapy].
    Mashkilleysson AL; Mashkilleysson NA
    Z Hautkr; 1983 Aug; 58(15):1127-9. PubMed ID: 6415945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effectiveness of local corticosteroid treatment for patients with various dermatoses].
    Kalamkarian AA; Makovoz VI; Samsonov VA
    Vrach Delo; 1971 Jan; (1):98-103. PubMed ID: 4252660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.